Detalhe da pesquisa
1.
Delineation of a new fibrillin-2-opathy with evidence for a role of FBN2 in the pathogenesis of carpal tunnel syndrome.
J Med Genet
; 58(11): 778-782, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32900841
2.
Efficacy and histopathological effects of self-assembling peptides RADA16 and IEIK13 in neurosurgical hemostasis.
Nanomedicine
; 40: 102485, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34748959
3.
Conditional mouse models support the role of SLC39A14 (ZIP14) in Hyperostosis Cranialis Interna and in bone homeostasis.
PLoS Genet
; 14(4): e1007321, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29621230
4.
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression.
Cancer Immunol Immunother
; 68(10): 1573-1583, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511925
5.
The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies.
Molecules
; 24(24)2019 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31817278
6.
Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants.
Tumour Biol
; 39(2): 1010428317694327, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240049
7.
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
J Hematol Oncol
; 17(1): 8, 2024 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331849
8.
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.
Antioxidants (Basel)
; 12(3)2023 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36978917
9.
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.
Oncoimmunology
; 12(1): 2192100, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970072
10.
Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
Cancer Drug Resist
; 6(4): 709-728, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239393
11.
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
NPJ Precis Oncol
; 7(1): 128, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066116
12.
The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
Front Immunol
; 13: 1001161, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268020
13.
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy.
Cancers (Basel)
; 14(17)2022 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077610
14.
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.
Pharmaceutics
; 14(12)2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36559255
15.
Prognostic implications of cellular senescence in resected non-small cell lung cancer.
Transl Lung Cancer Res
; 11(8): 1526-1539, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36090630
16.
Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.
Cells
; 10(11)2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34831159
17.
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.
Redox Biol
; 42: 101949, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812801
18.
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients.
Cancers (Basel)
; 12(4)2020 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32252405
19.
Determination of the Potential Tumor-Suppressive Effects of Gsdme in a Chemically Induced and in a Genetically Modified Intestinal Cancer Mouse Model.
Cancers (Basel)
; 11(8)2019 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434357
20.
In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53.
Mol Oncol
; 13(5): 1196-1213, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859681